Azulfidine RA 500 mg is a prescription medication containing sulfasalazine, a well-established anti-inflammatory and disease-modifying antirheumatic drug (DMARD) used in the treatment of chronic inflammatory disorders affecting the joints and gastrointestinal tract.
The medication is supplied as enteric-coated tablets designed to release the active ingredient in the intestinal tract, improving gastrointestinal tolerability during long-term therapy.
Brand Name: Azulfidine RA
Active Ingredient: Sulfasalazine
Strength: 500 mg
Dosage Form: Enteric-coated tablets
Pack Size: 300 tablets
Manufacturer: Pfizer
Sulfasalazine is a disease-modifying anti-inflammatory medication that has been used in clinical practice for decades. It works by reducing inflammatory activity and modulating immune responses involved in autoimmune and inflammatory diseases.
It remains one of the most widely prescribed conventional DMARD therapies worldwide.
Azulfidine RA 500 mg may be prescribed for:
To help reduce joint inflammation, pain, stiffness, and progression of structural joint damage.
In selected cases under specialist supervision.
For induction and maintenance of remission in inflammatory bowel disease.
In specific clinical situations as determined by a healthcare professional.
Sulfasalazine exerts anti-inflammatory and immunomodulatory effects by influencing inflammatory pathways involved in autoimmune diseases.
Potential therapeutic effects include:
Clinical benefits typically develop gradually over several weeks.
It is prescribed for rheumatoid arthritis, ulcerative colitis, and certain other chronic inflammatory conditions.
Each tablet contains 500 mg of sulfasalazine.
This package contains 300 enteric-coated tablets.
Therapeutic benefits usually develop gradually over several weeks of treatment.
Yes, it is commonly used for long-term disease management under medical supervision.
Regular monitoring of blood counts and liver function is often recommended during treatment.
Yes. Sulfasalazine is classified as a conventional disease-modifying antirheumatic drug (DMARD).
Yes. Azulfidine RA should only be used under the supervision of a qualified healthcare professional.
Ask a question or inquire about delivery to your country